查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813809

全球介入性心臟病學設備市場：市場規模、佔有率、趨勢分析（按產品和地區）、細分市場預測（2025-2033）

Interventional Cardiology Devices Market Size, Share & Trends Analysis Report By Product (Coronary Stents, PTCA Balloon Catheters, Intravascular Imaging Catheters and Pressure Guidewires, Accessory Devices), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

介入性心臟病學設備市場摘要

2024 年全球介入性心臟病設備市場價值估計為 105.7 億美元，預計到 2033 年將達到 197.5 億美元，2025 年至 2033 年的複合年成長率為 7.25%。

市場成長的動力包括心血管疾病盛行率的上升、對微創手術的需求的增加以及藥物釋放型支架和生物可吸收血管支架等技術的進步。

老年人口的不斷成長、醫療支出的不斷增加以及新興市場心臟護理服務可近性的改善也促進了市場擴張。產品創新以及人工智慧和影像技術在導管介入治療中的整合進一步推動了需求。心血管疾病盛行率的上升是主要的市場驅動力。久坐不動的生活方式、不良的飲食習慣以及肥胖和糖尿病發病率的上升導致全球冠狀動脈疾病和其他心臟疾病的發病率激增。日益加重的疾病負擔推動了對及時有效干預措施的需求，從而推動了支架、導管和其他介入工具的採用。

2024年10月，美國疾病管制與預防中心（CDC）報告稱，心臟病仍然是美國的主要死因，2023年導致超過91.9萬人死亡，佔總死亡人數的近三分之一。心血管疾病每34秒就會造成一人死亡，約5%的成年人罹患冠狀動脈疾病。 2020年至2021年，心臟病對美國經濟造成的醫療費用、藥物費用和生產力損失高達4,179億美元。

目錄

第1章 分析方法與範圍

第2章執行摘要

3.介入性心臟病學設備市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 介入性心臟病學設備市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析
  • 技術狀況
  • 案例研究分析

4. 全球介入性心臟病學設備市場分析（依產品分類）（2021-2033）

  • 定義和範圍
  • 按產品分類的市佔率分析（2024 年和 2033 年）
  • 細分儀表板
  • 全球介入性心臟病學設備市場（依產品分類）（2021-2033）
  • 冠狀動脈支架
    • 冠狀動脈支架市場估計與預測（2021-2033）
    • DES
    • BMS
    • BRS
  • PTCA球囊導管
    • PTCA球囊導管市場估計與預測（2021-2033）
    • 通常
    • 特別的
    • 藥物包衣
  • 血管內成像導管和壓力導管導引線
    • 血管內成像導管和壓力導管導引線市場估計和預測（2021-2033）
  • 附屬設備
    • 配件設備市場估計與預測（2021-2033）
    • PTCA導管導引線
    • PTCA引導管
    • 導引鞘

5. 介入性心臟病學設備市場按地區分析（2021-2033）

  • 各地區市佔率分析（2024 年及 2034 年）
  • 市場儀表板：按地區
  • 市場概述：按地區
  • 介入性心臟病學設備市場佔有率（按地區分類）（2024 年和 2033 年）
  • 北美洲
    • 北美介入性心臟病學設備市場（2021-2033）
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲介入性心臟病學設備市場（2021-2033）
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司簡介
    • Abbott
    • Medtronic plc
    • Boston Scientific Corporation
    • Cardinal Health, Inc.
    • Koninklijke Philips NV
    • Terumo Corporation
    • Alvimedica Medical Technologies Inc.
    • Teleflex Incorporated
    • B. Braun Melsungen AG
    • Biosensors International Group, Ltd.
    • Meril Life Sciences Pvt. Ltd.
    • BIOTRONIK SE &Co. KG.
    • ACIST Medical Systems, Inc.
    • Asahi Intecc Co., Ltd.
    • Cook Medical LLC
    • Medinol Ltd.
    • Merit Medical Systems, Inc.
    • NuMED, Inc.
    • OpSens Inc.
    • Zeon Medical Inc.
Product Code: 978-1-68038-122-1

Interventional Cardiology Devices Market Summary

The global interventional cardiology devices market size was estimated at USD 10.57 billion in 2024 and is projected to reach USD 19.75 billion by 2033, growing at a CAGR of 7.25% from 2025 to 2033. The market growth is driven by the rising prevalence of cardiovascular diseases, increased demand for minimally invasive procedures, and technological advancements such as drug-eluting stents and bioresorbable vascular scaffolds.

The expanding elderly population, rising healthcare spending, and improved access to cardiac care in emerging markets also contribute to market expansion. Product innovation and integration of AI and imaging in catheter-based interventions further fuel demand. The rising prevalence of cardiovascular diseases is a primary market driver. Sedentary lifestyles, poor dietary habits, and increasing rates of obesity and diabetes have led to a global surge in coronary artery disease and other cardiac conditions. This growing disease burden has increased the demand for timely and effective interventions, boosting the adoption of stents, catheters, and other interventional tools.

In October 2024, the CDC reported that heart disease continues to be the top cause of death in the U.S., responsible for more than 919,000 deaths in 2023, or roughly one-third of all fatalities. A person dies from cardiovascular disease every 34 seconds, and around 5% of adults are affected by coronary artery disease. Between 2020 and 2021, heart disease incurred a financial toll of USD 417.9 billion in healthcare costs, medications, and lost productivity.

Global Interventional Cardiology Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country-level and provides an analysis of the latest industry trends in each of the sub-segments from 2021-2033. For this study, Grand View Research, Inc. has segmented the global Interventional cardiology devices market report based on product and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Coronary Stents
    • DES
    • BMS
    • BRS
  • PTCA Balloon Catheters
  • Normal
  • Specialty
  • Drug-Coated
  • Intravascular Imaging Catheters and Pressure Guidewires
  • Accessory Devices
    • PTCA Guidewires
    • PTCA Guiding Catheters
    • Introducer Sheaths
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
  • 2.3. Competitive Insights

Chapter 3. Global Interventional Cardiology Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Global Interventional Cardiology Devices: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Technology Landscape
  • 3.5. Case Study Analysis

Chapter 4. Global Interventional Cardiology Devices Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Interventional Cardiology Devices Market, by Product, 2021 - 2033
  • 4.5. Coronary Stents
    • 4.5.1. Coronary stents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. DES
      • 4.5.2.1. DES market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. BMS
      • 4.5.3.1. BMS market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. BRS
      • 4.5.4.1. BRS market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. PTCA Balloon Catheters
    • 4.6.1. PTCA balloon catheters market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Normal
      • 4.6.2.1. Normal market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Specialty
      • 4.6.3.1. Specialty market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Drug-Coated
      • 4.6.4.1. Drug-coated market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Intravascular Imaging Catheters and Pressure Guidewires
    • 4.7.1. Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Accessory devices
    • 4.8.1. Accessory devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.2. PTCA Guidewires
      • 4.8.2.1. PTCA guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.3. PTCA Guiding Catheters
      • 4.8.3.1. PTCA guiding catheters market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.4. Introducer Sheaths
      • 4.8.4.1. Introducer sheaths market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Interventional Cardiology Devices Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

  • 5.1. Regional Market Share Analysis, 2024 & 2034
  • 5.2. Regional Market Dashboard
  • 5.3. Regional Market Snapshot
  • 5.4. Interventional Cardiology Devices Market Share by Region, 2024 & 2033:
  • 5.5. North America
    • 5.5.1. North America Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.5.2. U.S.
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Scenario
      • 5.5.2.3. Competitive Scenario
      • 5.5.2.4. U.S. Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.5.3. Canada
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Scenario
      • 5.5.3.3. Competitive Scenario
      • 5.5.3.4. Canada Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Scenario
      • 5.5.4.3. Competitive Scenario
      • 5.5.4.4. Mexico Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
  • 5.6. Europe
    • 5.6.1. Europe Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.2. UK
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Scenario
      • 5.6.2.3. Competitive Scenario
      • 5.6.2.4. UK Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.3. Germany
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Scenario
      • 5.6.3.3. Competitive Scenario
      • 5.6.3.4. Germany Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.4. France
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Scenario
      • 5.6.4.3. Competitive Scenario
      • 5.6.4.4. France Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.5. Italy
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Scenario
      • 5.6.5.3. Competitive Scenario
      • 5.6.5.4. Italy Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.6. Spain
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Scenario
      • 5.6.6.3. Competitive Scenario
      • 5.6.6.4. Spain Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.7. Norway
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Scenario
      • 5.6.7.3. Competitive Scenario
      • 5.6.7.4. Norway Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.8. Sweden
      • 5.6.8.1. Key Country Dynamics
      • 5.6.8.2. Regulatory Scenario
      • 5.6.8.3. Competitive Scenario
      • 5.6.8.4. Sweden Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.6.9. Denmark
      • 5.6.9.1. Key Country Dynamics
      • 5.6.9.2. Regulatory Scenario
      • 5.6.9.3. Competitive Scenario
      • 5.6.9.4. Denmark Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Japan
      • 5.7.1.1. Key Country Dynamics
      • 5.7.1.2. Regulatory Scenario
      • 5.7.1.3. Competitive Scenario
      • 5.7.1.4. Japan Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.7.2. China
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Scenario
      • 5.7.2.3. Competitive Scenario
      • 5.7.2.4. China Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.7.3. India
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Scenario
      • 5.7.3.3. Competitive Scenario
      • 5.7.3.4. India Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.7.4. Australia
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Regulatory Scenario
      • 5.7.4.3. Competitive Scenario
      • 5.7.4.4. Australia Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.7.5. South Korea
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Regulatory Scenario
      • 5.7.5.3. Competitive Scenario
      • 5.7.5.4. South Korea Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.7.6. Thailand
      • 5.7.6.1. Key Country Dynamics
      • 5.7.6.2. Regulatory Scenario
      • 5.7.6.3. Competitive Scenario
      • 5.7.6.4. Thailand Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Brazil
      • 5.8.1.1. Key Country Dynamics
      • 5.8.1.2. Regulatory Scenario
      • 5.8.1.3. Competitive Scenario
      • 5.8.1.4. Brazil Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.8.2. Argentina
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Scenario
      • 5.8.2.3. Competitive Scenario
      • 5.8.2.4. Argentina Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
  • 5.9. MEA
    • 5.9.1. South Africa
      • 5.9.1.1. Key Country Dynamics
      • 5.9.1.2. Regulatory Scenario
      • 5.9.1.3. Competitive Scenario
      • 5.9.1.4. South Africa Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.9.2. Saudi Arabia
      • 5.9.2.1. Key Country Dynamics
      • 5.9.2.2. Regulatory Scenario
      • 5.9.2.3. Competitive Scenario
      • 5.9.2.4. Saudi Arabia Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.9.3. UAE
      • 5.9.3.1. Key Country Dynamics
      • 5.9.3.2. Regulatory Scenario
      • 5.9.3.3. Competitive Scenario
      • 5.9.3.4. UAE Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)
    • 5.9.4. Kuwait
      • 5.9.4.1. Key Country Dynamics
      • 5.9.4.2. Regulatory Scenario
      • 5.9.4.3. Competitive Scenario
      • 5.9.4.4. Kuwait Interventional Cardiology Devices Market, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Profiles
    • 6.3.1. Abbott
      • 6.3.1.1. Company overview
      • 6.3.1.2. Financial performance
      • 6.3.1.3. Product benchmarking
      • 6.3.1.4. Strategic initiatives
    • 6.3.2. Medtronic plc
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Product benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. Boston Scientific Corporation
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Product benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. Cardinal Health, Inc.
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Koninklijke Philips N.V.
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Terumo Corporation
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Alvimedica Medical Technologies Inc.
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Teleflex Incorporated
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. B. Braun Melsungen AG
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Biosensors International Group, Ltd.
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Meril Life Sciences Pvt. Ltd.
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. BIOTRONIK SE & Co. KG.
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. ACIST Medical Systems, Inc.
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives
    • 6.3.14. Asahi Intecc Co., Ltd.
      • 6.3.14.1. Company overview
      • 6.3.14.2. Financial performance
      • 6.3.14.3. Product benchmarking
      • 6.3.14.4. Strategic initiatives
    • 6.3.15. Cook Medical LLC
      • 6.3.15.1. Company overview
      • 6.3.15.2. Financial performance
      • 6.3.15.3. Product benchmarking
      • 6.3.15.4. Strategic initiatives
    • 6.3.16. Medinol Ltd.
      • 6.3.16.1. Company overview
      • 6.3.16.2. Financial performance
      • 6.3.16.3. Product benchmarking
      • 6.3.16.4. Strategic initiatives
    • 6.3.17. Merit Medical Systems, Inc.
      • 6.3.17.1. Company overview
      • 6.3.17.2. Financial performance
      • 6.3.17.3. Product benchmarking
      • 6.3.17.4. Strategic initiatives
    • 6.3.18. NuMED, Inc.
      • 6.3.18.1. Company overview
      • 6.3.18.2. Financial performance
      • 6.3.18.3. Product benchmarking
      • 6.3.18.4. Strategic initiatives
    • 6.3.19. OpSens Inc.
      • 6.3.19.1. Company overview
      • 6.3.19.2. Financial performance
      • 6.3.19.3. Product benchmarking
      • 6.3.19.4. Strategic initiatives
    • 6.3.20. Zeon Medical Inc.
      • 6.3.20.1. Company overview
      • 6.3.20.2. Financial performance
      • 6.3.20.3. Product benchmarking
      • 6.3.20.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 4 U.S. Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 5 Canada Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 6 Mexico Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 7 Europe Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 8 UK Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 9 Germany Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 10 France Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 11 Italy Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 12 Spain Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 13 Sweden Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 14 Denmark Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 15 Norway Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 16 Asia Pacific Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 17 Japan Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 18 China Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 19 India Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 20 Australia Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 21 South Korea Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 22 Thailand Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 23 Latin America Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 24 Brazil Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 25 Argentina Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 26 MEA Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 27 South Africa Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 28 Saudi Arabia Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 29 UAE Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)
  • Table 30 Kuwait Interventional cardiology devices market, by product, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Interventional cardiology devices: market outlook
  • Fig. 9 Interventional cardiology devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Interventional cardiology devices driver impact
  • Fig. 13 Interventional cardiology devices restraint impact
  • Fig. 14 Interventional cardiology devices strategic initiatives analysis
  • Fig. 15 Interventional cardiology devices: Product movement analysis
  • Fig. 16 Interventional cardiology devices: Product outlook and key takeaways
  • Fig. 17 Coronary stents market estimates and forecasts, 2021 - 2033
  • Fig. 18 DES market estimates and forecasts, 2021 - 2033
  • Fig. 19 BMS market estimates and forecasts, 2021 - 2033
  • Fig. 20 BRS market estimates and forecasts, 2021 - 2033
  • Fig. 21 PTCA balloon catheters market estimates and forecasts, 2021 - 2033
  • Fig. 22 Normal market estimates and forecasts, 2021 - 2033
  • Fig. 23 Specialty market estimates and forecasts, 2021 - 2033
  • Fig. 24 Drug-coated market estimates and forecasts, 2021 - 2033
  • Fig. 25 Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2021 - 2033
  • Fig. 26 Accessory devices market estimates and forecasts, 2021 - 2033
  • Fig. 27 PTCA guidewires market estimates and forecasts, 2021 - 2033
  • Fig. 28 PTCA guiding catheters market estimates and forecasts, 2021 - 2033
  • Fig. 29 Introducer sheaths market estimates and forecasts, 2021 - 2033
  • Fig. 30 Global Interventional cardiology devices market: Regional movement analysis
  • Fig. 31 Global Interventional cardiology devices market: Regional outlook and key takeaways
  • Fig. 32 North America Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 U.S. Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Canada Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Mexico Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Europe Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Spain Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 France Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Norway Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Sweden Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Asia Pacific Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 China Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 India Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Latin America Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Brazil Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Mexico Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Argentina Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 MEA Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Africa Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Saudi Arabia Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 UAE Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Kuwait Interventional cardiology devices market estimates and forecasts, 2021 - 2033 (USD Million)